How to buy Living Cell Technologies shares | A$0.015

Living Cell Technologies Limited is a biotechnology business based in Australia. Living Cell Technologies shares (LCT) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.015 – the same closing value as a week prior. Living Cell Technologies has a trailing 12-month revenue of around $553,692.

How to buy shares in Living Cell Technologies

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Living Cell Technologies . Find the share by name or ticker symbol: LCT. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Living Cell Technologies reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $0.015, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Living Cell Technologies . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Living Cell Technologies 's share price?

Since the stock market crash in March caused by coronavirus, Living Cell Technologies 's share price has had significant negative movement.

Its last market close was $0.015, which is 21.05% down on its pre-crash value of $0.019 and 66.67% up on the lowest point reached during the March crash when the shares fell as low as $0.009.

If you had bought $1,000 worth of Living Cell Technologies shares at the start of February 2020, those shares would have been worth $526.32 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $789.47.

Living Cell Technologies share price

Use our graph to track the performance of LCT stocks over time.

Living Cell Technologies shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	AUDA$0.015
52-week range	AUDA$0.009 - AUDA$0.022
50-day moving average	AUDA$0.0158
200-day moving average	AUDA$0.0143
Target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.006

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Living Cell Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Living Cell Technologies Limited by TradingView

Living Cell Technologies price performance over time

Historical closes compared with the close of A$0.015 on 2020-10-22

1 week (2020-10-22)	0%
1 month (2020-09-29)	-6.25%
3 months (2020-07-29)	15.38%
6 months (2020-04-29)	7.14%

1 year (2019-10-29)	-31.82%
2 years (2018-10-29)	-70.00%
3 years (2017-10-27)	-93.62%
5 years (2015-10-29)	-71.70%

Living Cell Technologies financials

Revenue TTM	$553,692
Gross profit TTM	$553,692
Return on assets TTM	-32.18%
Return on equity TTM	-27.6%
Profit margin	-174.91%
Book value	0.005
Market capitalisation	$9.1 million

TTM: trailing 12 months

Living Cell Technologies share dividends

We're not expecting Living Cell Technologies to pay a dividend over the next 12 months.

Living Cell Technologies share price volatility

Over the last 12 months, Living Cell Technologies 's shares have ranged in value from as little as $0.009 up to $0.022. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Living Cell Technologies 's is 0.9729. This would suggest that Living Cell Technologies 's shares are less volatile than average (for this exchange).

Living Cell Technologies overview

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. The company's lead product is NTCELL, an alginate coated capsule, which is in clinical trials for the treatment of Parkinson's disease. It also develops LP-003, a peptide drug that reduces caloric intake targeting obesity; and LC-002, a novel calcitonin gene-related peptide antagonist targeting migraine. Living Cell Technologies Limited has a research collaboration agreement with the University of Auckland to identify products that utilize patented novel peptide synthetic chemistry technology for the treatments for obesity and migraine. The company was founded in 1987 and is based in Melbourne, Australia.

Frequently asked questions

• What percentage of Living Cell Technologies is owned by insiders or institutions?

  Currently 25.459% of Living Cell Technologies shares are held by insiders and 6.314% by institutions.

• When does the fiscal year end for Living Cell Technologies ?

  Living Cell Technologies 's fiscal year ends in June.

• Where is Living Cell Technologies based?

  Living Cell Technologies 's address is: 330 Collins Street, Melbourne, VIC, Australia, 3000

• What is Living Cell Technologies 's ISIN number?

  Living Cell Technologies 's international securities identification number is: AU000000LCT6